CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes

J Asthma Allergy. 2021 Oct 7;14:1209-1215. doi: 10.2147/JAA.S333098. eCollection 2021.

Abstract

Anaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option.

Keywords: COVID-19; COVID-19 vaccine; anaphylaxis; drug allergy; excipient; skin testing; vaccine allergy.

Publication types

  • Case Reports